Dados B3 › HAGA4 × SUZB3
HAGA4 × SUZB3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | HAGA4 | SUZB3 | year |
|---|---|---|---|
| ROE | — | 35.2% | no year where both have it |
| ROIC | — | 6.2% | no year where both have it |
| ROA | 3.2% | 8.0% | 2025 |
| Gross margin | 23.1% | 32.4% | 2025 |
| EBIT margin | -3.4% | 21.2% | 2025 |
| Net margin | 7.5% | 26.8% | 2025 |
| Net debt/EBITDA | — | 3.18x | no year where both have it |
| Current ratio | 2.60x | 3.19x | 2025 |
| Revenue growth (1y) | -3.6% | 5.7% | 2025 |
| Revenue growth (5y CAGR) | -0.9% | 10.5% | 2025 |
| Piotroski F-Score | 3/9! | 8/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | HAGA4 | SUZB3 | year |
|---|---|---|---|
| P/E | 2.12x | 4.71x | 2022 × 2025 |
| P/B | — | 1.44x | 2022 × 2025 |
| EV/EBITDA | — | 6.05x | 2022 × 2025 |
| FCF yield | — | 21.4% | 2022 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 12:04 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 12:04 UTC. If this does not match /saude, you are reading a cached copy.